Trial begins. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases31

Neoplasms Recurrence Breast Neoplasms Stroke Disease Progression Acute Disease Lung Neoplasms Chronic Disease HIV Infections Pain Myocardial Infarction Neoplasm Recurrence, Local Cardiovascular Diseases Postoperative Complications Nausea Diabetes Mellitus, Type 2 Weight Loss Colorectal Neoplasms Drug-Related Side Effects and Adverse Reactions Fatigue Prostatic Neoplasms Neoplasm Metastasis Hemorrhage Heart Failure Vomiting Hypertension Carcinoma, Non-Small-Cell Lung Weight Gain Neutropenia Body Weight Low Back Pain

Chemicals and Drugs42

Placebos Antineoplastic Agents Drug Combinations Fluorouracil Antibodies, Monoclonal, Humanized Paclitaxel Antibodies, Monoclonal Cisplatin Drugs, Investigational Biological Markers Cyclophosphamide Deoxycytidine Platelet Aggregation Inhibitors Methotrexate Doxorubicin Anti-Bacterial Agents Anticoagulants Antihypertensive Agents Fibrinolytic Agents Aspirin Cardiovascular Agents Hydroxymethylglutaryl-CoA Reductase Inhibitors Prednisone Hypoglycemic Agents Antidepressive Agents Taxoids Vincristine Antineoplastic Agents, Hormonal Recombinant Proteins Vitamins Immunosuppressive Agents Adrenal Cortex Hormones Tamoxifen AIDS Vaccines Anti-Inflammatory Agents Carboplatin Vinblastine Antipsychotic Agents Pyrroles Anti-HIV Agents Antimetabolites, Antineoplastic Blood Glucose

Analytical, Diagnostic and Therapeutic Techniques and Equipment99

Clinical Trials as Topic Clinical Trials, Phase III as Topic Double-Blind Method Research Design Clinical Trials, Phase II as Topic Clinical Trials, Phase I as Topic Controlled Clinical Trials as Topic Treatment Outcome Placebos Clinical Protocols Follow-Up Studies Patient Selection Early Termination of Clinical Trials Single-Blind Method Prospective Studies Multicenter Studies as Topic Drug Administration Schedule Drug Therapy, Combination Sample Size Antineoplastic Combined Chemotherapy Protocols Pilot Projects Clinical Trials, Phase IV as Topic Combined Modality Therapy Survival Analysis Administration, Oral Severity of Illness Index Cross-Over Studies Risk Factors Questionnaires Disease-Free Survival Feasibility Studies Exercise Therapy Random Allocation Survival Rate Pain Measurement Risk Assessment Infusions, Intravenous Prognosis Drug Evaluation Meta-Analysis as Topic Data Interpretation, Statistical Kaplan-Meier Estimate Reproducibility of Results Analysis of Variance Chemotherapy, Adjuvant Treatment Failure Therapeutic Human Experimentation Cluster Analysis Proportional Hazards Models Neoplasm Staging Program Evaluation Predictive Value of Tests Phytotherapy Retrospective Studies Incidence Quality-Adjusted Life Years Self Care Chi-Square Distribution Statistics, Nonparametric Control Groups Remission Induction Cohort Studies Drug Approval Multivariate Analysis Physical Therapy Modalities Therapy, Computer-Assisted Confidence Intervals Mass Screening Regression Analysis Risk Disability Evaluation Maximum Tolerated Dose Odds Ratio Logistic Models Sensitivity and Specificity Administration, Topical Models, Statistical Probability Angioplasty, Balloon, Coronary Blood Pressure Linear Models Pain Management Statistics as Topic Magnetic Resonance Imaging Injections, Intravenous Length of Stay Hospitalization Activities of Daily Living Injections, Intramuscular Administration, Intravaginal Stents Radiotherapy, Adjuvant Human Experimentation Data Collection Fluid Therapy Postoperative Care Body Weight Chemoprevention Thrombolytic Therapy

Psychiatry and Psychology18

Patient Compliance Cognitive Therapy Counseling Pain Risk Reduction Behavior Motivation Behavior Therapy Smoking Cessation Psychiatric Status Rating Scales Decision Making Health Knowledge, Attitudes, Practice Reaction Time Depression Psychomotor Performance Cognition Psychotherapy Motor Activity Anxiety

Phenomena and Processes23

Time Factors Dose-Response Relationship, Drug Trial of Labor Pregnancy Pain Exercise Chi-Square Distribution Recovery of Function Diet Weight Loss Risk Maximum Tolerated Dose Reaction Time Odds Ratio Sensitivity and Specificity Probability Blood Pressure Psychomotor Performance Walking Motor Activity Postmenopause Weight Gain Body Weight

Disciplines and Occupations10

Research Design Outcome Assessment (Health Care)Evidence-Based Medicine Therapeutic Human Experimentation Biomedical Research Medical Oncology Statistics as Topic Comparative Effectiveness Research Research Report Human Experimentation

Anthropology, Education, Sociology and Social Phenomena10

Quality of Life Patient Education as Topic Informed Consent Exercise Drug Approval United States Food and Drug Administration Health Education Walking Activities of Daily Living National Institutes of Health (U.S.)

Technology, Industry, Agriculture4

Dietary Supplements Drug Industry Vitamins Quality Control

Humanities2

Quality of Life Therapeutic Equipoise

Information Science15

Questionnaires Survival Rate Data Interpretation, Statistical Publishing Publication Bias Incidence Quality-Adjusted Life Years Internet Pamphlets Therapy, Computer-Assisted Telephone Review Literature as Topic Periodicals as Topic Research Report Data Collection

Named Groups4

Research Subjects Patient Dropouts Infant, Newborn Research Personnel

Health Care93

Clinical Trials as Topic Clinical Trials, Phase III as Topic Double-Blind Method Clinical Trials, Phase II as Topic Clinical Trials, Phase I as Topic Controlled Clinical Trials as Topic Treatment Outcome Clinical Protocols Follow-Up Studies Patient Selection Early Termination of Clinical Trials Single-Blind Method Prospective Studies Multicenter Studies as Topic Clinical Trials Data Monitoring Committees Sample Size Cost-Benefit Analysis Pilot Projects Clinical Trials, Phase IV as Topic Outcome Assessment (Health Care)Survival Analysis Patient Compliance Severity of Illness Index Cross-Over Studies Intention to Treat Analysis Risk Factors Questionnaires Disease-Free Survival Feasibility Studies Random Allocation Survival Rate Risk Assessment Placebo Effect Patient Education as Topic Meta-Analysis as Topic Data Interpretation, Statistical Patient Satisfaction Informed Consent Kaplan-Meier Estimate Reproducibility of Results Analysis of Variance Patient Participation Treatment Failure Bias (Epidemiology)Counseling Cluster Analysis Proportional Hazards Models Program Evaluation Predictive Value of Tests Retrospective Studies Incidence Research Support as Topic Safety Practice Guidelines as Topic Age Factors Quality-Adjusted Life Years Health Care Costs Health Promotion Self Care Chi-Square Distribution Statistics, Nonparametric Cohort Studies Multivariate Analysis Primary Health Care Confidence Intervals Mass Screening Regression Analysis Guidelines as Topic United States Food and Drug Administration Risk Health Knowledge, Attitudes, Practice Odds Ratio Selection Bias Logistic Models Sensitivity and Specificity Models, Statistical Probability Linear Models Pain Management Outcome and Process Assessment (Health Care)Health Education Statistics as Topic Comparative Effectiveness Research Length of Stay Costs and Cost Analysis Hospitalization Activities of Daily Living National Institutes of Health (U.S.)Community Health Services Home Care Services Primary Prevention Data Collection Postoperative Care

Geographicals7

United States Great Britain Netherlands Europe Australia Germany Canada

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Clinical Trials as Topic Clinical Trials, Phase III as Topic Double-Blind Method Research Design Clinical Trials, Phase II as Topic Clinical Trials, Phase I as Topic Controlled Clinical Trials as Topic Treatment Outcome Placebos Time Factors Clinical Protocols Follow-Up Studies Patient Selection Early Termination of Clinical Trials Single-Blind Method Prospective Studies Multicenter Studies as Topic Clinical Trials Data Monitoring Committees Drug Administration Schedule Drug Therapy, Combination Sample Size Quality of Life Cost-Benefit Analysis Antineoplastic Combined Chemotherapy Protocols Pilot Projects Clinical Trials, Phase IV as Topic Outcome Assessment (Health Care)Neoplasms Antineoplastic Agents Combined Modality Therapy Survival Analysis Patient Compliance Administration, Oral Severity of Illness Index Recurrence Cross-Over Studies Intention to Treat Analysis Evidence-Based Medicine Risk Factors Dose-Response Relationship, Drug Dietary Supplements Questionnaires Disease-Free Survival Feasibility Studies Exercise Therapy Random Allocation Research Subjects Survival Rate United States Pain Measurement Cognitive Therapy Trial of Labor Risk Assessment Placebo Effect Infusions, Intravenous Breast Neoplasms Stroke Prognosis Patient Education as Topic Drug Evaluation Meta-Analysis as Topic Data Interpretation, Statistical Patient Satisfaction Disease Progression Informed Consent Drug Combinations Kaplan-Meier Estimate Reproducibility of Results Analysis of Variance Patient Participation Chemotherapy, Adjuvant Treatment Failure Patient Dropouts Great Britain Acute Disease Lung Neoplasms Bias (Epidemiology)Pregnancy Chronic Disease Therapeutic Human Experimentation Publishing HIV Infections Fluorouracil Counseling Pain Exercise Myocardial Infarction Antibodies, Monoclonal, Humanized Biomedical Research Paclitaxel Infant, Newborn Cluster Analysis Proportional Hazards Models Antibodies, Monoclonal Neoplasm Staging Cisplatin Drugs, Investigational Risk Reduction Behavior Biological Markers Publication Bias

No FAQ available that match "trial begins"